These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 3606905)
1. Monitoring fluoride therapy in osteoporosis by dual photon absorptiometry. Raymakers JA; van Dijke CF; Hoekstra A; Duursma SA Bone; 1987; 8(3):143-8. PubMed ID: 3606905 [TBL] [Abstract][Full Text] [Related]
2. Postmenopausal osteoporosis: treatment with low-dose sodium fluoride and estrogen. Lueg MC South Med J; 1988 May; 81(5):597-600. PubMed ID: 2835819 [TBL] [Abstract][Full Text] [Related]
3. The value of local 99mTc(Sn)-MDP bone to soft tissue uptake ratio in osteoporosis, before and during fluoride therapy. Raymakers JA; Savelkoul TJ; Hoekstra A; Visser WJ; van Rijk PP; Duursma SA Eur J Nucl Med; 1990; 16(3):157-60. PubMed ID: 2364958 [TBL] [Abstract][Full Text] [Related]
4. Fracture prevalence and bone mineral mass in osteoporosis measured with computed tomography and dual energy photon absorptiometry. Raymakers JA; Hoekstra O; van Putten J; Kerkhoff H; Duursma SA Skeletal Radiol; 1986; 15(3):191-7. PubMed ID: 3704672 [TBL] [Abstract][Full Text] [Related]
5. Safe and effective treatment of osteoporosis with intermittent slow release sodium fluoride: augmentation of vertebral bone mass and inhibition of fractures. Pak CY; Sakhaee K; Zerwekh JE; Parcel C; Peterson R; Johnson K J Clin Endocrinol Metab; 1989 Jan; 68(1):150-9. PubMed ID: 2909549 [TBL] [Abstract][Full Text] [Related]
6. Reduced bone mass in daughters of women with osteoporosis. Seeman E; Hopper JL; Bach LA; Cooper ME; Parkinson E; McKay J; Jerums G N Engl J Med; 1989 Mar; 320(9):554-8. PubMed ID: 2915666 [TBL] [Abstract][Full Text] [Related]
7. A randomized trial of sodium fluoride (60 mg) +/- estrogen in postmenopausal osteoporotic vertebral fractures: increased vertebral fractures and peripheral bone loss with sodium fluoride; concurrent estrogen prevents peripheral loss, but not vertebral fractures. Gutteridge DH; Stewart GO; Prince RL; Price RI; Retallack RW; Dhaliwal SS; Stuckey BG; Drury P; Jones CE; Faulkner DL; Kent GN; Bhagat CI; Nicholson GC; Jamrozik K Osteoporos Int; 2002; 13(2):158-70. PubMed ID: 11908491 [TBL] [Abstract][Full Text] [Related]
8. Assessment by reflection ultrasound method of the effect of intermittent slow-release sodium fluoride-calcium citrate therapy on material strength of bone. Zerwekh JE; Antich PP; Sakhaee K; Gonzales J; Gottschalk F; Pak CY J Bone Miner Res; 1991 Mar; 6(3):239-44. PubMed ID: 2035350 [TBL] [Abstract][Full Text] [Related]
9. Treatment of osteoporosis with human parathyroid peptide and observations on effect of sodium fluoride. Reeve J; Davies UM; Hesp R; McNally E; Katz D BMJ; 1990 Aug; 301(6747):314-8. PubMed ID: 2393738 [TBL] [Abstract][Full Text] [Related]
10. Sodium fluoride prevents bone loss in primary biliary cirrhosis. Guañabens N; Parés A; del Rio L; Roca M; Gómez R; Muñoz J; Rodés J J Hepatol; 1992 Jul; 15(3):345-9. PubMed ID: 1447501 [TBL] [Abstract][Full Text] [Related]
11. The effect of fluoride and calcium on spinal bone mineral content: a controlled, prospective (3 years) study. Hansson T; Roos B Calcif Tissue Int; 1987 Jun; 40(6):315-7. PubMed ID: 3111669 [TBL] [Abstract][Full Text] [Related]
12. Combination therapy for osteoporosis with estrogen, fluoride, and calcium. Aloia JF; Zanzi I; Vaswani A; Ellis K; Cohn SH J Am Geriatr Soc; 1982 Jan; 30(1):13-7. PubMed ID: 7056975 [TBL] [Abstract][Full Text] [Related]
13. Long term effect of oestrogen replacement therapy on bone mass as measured by dual photon absorptiometry. Al-Azzawi F; Hart DM; Lindsay R Br Med J (Clin Res Ed); 1987 May; 294(6582):1261-2. PubMed ID: 3109607 [No Abstract] [Full Text] [Related]
14. A prospective study of risedronate on regional bone metabolism and blood flow at the lumbar spine measured by 18F-fluoride positron emission tomography. Frost ML; Cook GJ; Blake GM; Marsden PK; Benatar NA; Fogelman I J Bone Miner Res; 2003 Dec; 18(12):2215-22. PubMed ID: 14672357 [TBL] [Abstract][Full Text] [Related]
15. Osteoporosis: radiographic detection of fluoride-induced extra-axial bone formation. Schulz EE; Engstrom H; Sauser DD; Baylink DJ Radiology; 1986 May; 159(2):457-62. PubMed ID: 3961177 [TBL] [Abstract][Full Text] [Related]
16. [Effects of the combined raloxifene-sodium fluoride therapy on bone mass and bone turnover in women with postmenopausal osteoporosis]. Celi M; Letizia C; Ragno A; Minisola S; D'Erasmo E; Mazzuoli GF Minerva Med; 2002 Dec; 93(6):471-8. PubMed ID: 12515970 [TBL] [Abstract][Full Text] [Related]
17. Therapy of osteoporosis in patients with Crohn's disease: a randomized study comparing sodium fluoride and ibandronate. von Tirpitz C; Klaus J; Steinkamp M; Hofbauer LC; Kratzer W; Mason R; Boehm BO; Adler G; Reinshagen M Aliment Pharmacol Ther; 2003 Mar; 17(6):807-16. PubMed ID: 12641503 [TBL] [Abstract][Full Text] [Related]
18. Calcaneal ultrasonometry: response to treatment in comparison with dual x-ray absorptiometry measurements of the lumbar spine and femur. Rosenthall L; Caminis J; Tenehouse A Calcif Tissue Int; 1999 Mar; 64(3):200-4. PubMed ID: 10024375 [TBL] [Abstract][Full Text] [Related]
19. Osteoporosis in inflammatory bowel disease: effect of calcium and vitamin D with or without fluoride. Abitbol V; Mary JY; Roux C; Soulé JC; Belaiche J; Dupas JL; Gendre JP; Lerebours E; Chaussade S; Aliment Pharmacol Ther; 2002 May; 16(5):919-27. PubMed ID: 11966500 [TBL] [Abstract][Full Text] [Related]
20. Bone mineral content in early-postmenopausal and postmenopausal osteoporotic women: comparison of measurement methods. Reinbold WD; Genant HK; Reiser UJ; Harris ST; Ettinger B Radiology; 1986 Aug; 160(2):469-78. PubMed ID: 3726129 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]